Liposomes and lipid nanoparticles (LNPs) are becoming established as leading materials for the encapsulation and in vivo delivery of a wide range of clinical materials, including drugs, therapeutic agents, mRNA and other APIs. This technology is now used for a wide range of applications, spanning vaccine development, nanomedicines and gene therapy. Optimizing LNP formulations and screening target APIs/payloads requires a combination of flexible LNP synthesis and insightful characterization equipment.
Join this collaborative webinar with nanoparticle characterization experts Ben Knappett and Hanna Jankevics Jones, as they share their insights about the most important considerations when making liposomes and lipid nanoparticles (LNPs) with microfluidics.
Date: 21st October 2021
Time: 15:30 – 16:30 BST | 10:30 – 11:30 EDT
Event type: Webinar – Live
Read our new Application Note on the controlled synthesis of lipid nanoparticles using the ANP System and learn about the research done by our Experts on the key parameters involved in tuning LNPs’ size, and a comparison between the protocol and continuous mode to demonstrate the transferability of the process parameters for bulk production of LNPs.